Back to the solutions

Smart liquid biopsy panels with selected key genes per tumor type

Order an OncoSELECT

I am a patient

See how our solutions can help you in the treatment of cancer.

See case reports

OncoSELECT Solution

OncoSELECT is a fast, minimally invasive analysis of circulating tumour DNA from a blood sample for lung (NSCLC), colon, breast (ER+ or HER2+) cancer patients.
It is the perfect tool to identify therapeutic solutions for cancer patients not able to get their tumor biopsied, to monitor the evolution of their cancer and to detect treatment resistance as soon as it appears.

Description

According to a recent change in FDA guidelines, liquid biopsy is now approved as the first diagnostic tool for Non-Small Cell Lung Cancer patients. OncoSELECT is the perfect test to make a first screening of the most relevant genes related to treatments.

OncoSELECT targets more than 100 mutations of resistance and sensitivity to targeted therapies (SNV, Indel, translocation and CNV) as well as specific genes selected for each cancer type.

Advantages

To select a therapy: mainly for patients whose tissue sample is not available or limiting, when it is challenging or not possible to perform a biopsy of the primary tumour or of any metastasis, or if the biopsy sample is too old.

As a monitoring tool: it is the right way to monitor the tumour response to the treatment, detect potential resistance, adapt the treatment and doing so, extend the patient’s life. It is fast, minimally invasive for the patient and more sensitive than routine imaging.

How much does OncoSELECT cost?

Suggested price

1290 Eur

Country-specific price differences

The price indicated here is the recommended retail price. This price might vary in your country, depending on different factors like importation fees, freight costs, currency exchange rate, …
For more info or to order this product in your region, please contact our local representative.

Reimbursement statement

Currently our tests are reimbursed in a growing number of countries. In the United Kingdom, OncoSTRAT&GO is reimbursed for patients insured by BUPA Global Insurance, using code 7331B. Other countries, like Spain, Chili, South Africa or Poland, are also covering totally or partially the cost of our tests. Don’t hesitate to contact us for more information.

How to get OncoSELECT?

Ordering a solution is very simple: just log into OncoSHARE, select your solution(s) and pay. If you don’t have a kit, we’ll send you one.

The case report

Alicia, 49 years old when diagnosed

Was given the OncoDEEP solution following a stage 3 lung cancer.

View Alicia's report